| Name | α-HNJNAc |
|---|
| Description | α-HNJNAc is a potent, competitive hexosaminidases inhibitor without interfering with other glycosidases[1]. |
|---|---|
| Related Catalog | |
| In Vitro | α-HNJNAc (10, 100µM) shows no effect on GM00737 and GM01426 cell lines, but some effect on GM02931 cell line with a significant 1.8 fold activity increase. a-HNJNAc (100µM; 3 days) has no toxicity on human HL60 cell proliferation[1]. NAGLU is inhibited more efficiently by a-HNJNAc (67 µM) than by the uncorrectly configured b-HNJNAc (374 µM)[1]. |
| References |
| Molecular Formula | C9H18N2O5 |
|---|---|
| Molecular Weight | 234.25 |